Science Creates is a Deep Tech ecosystem that enables scientists and engineers to build disruptive businesses. Science Creates believes that Deep Tech startups are society's most effective economic vehicle to deliver innovation and global impact for the health of people and the health of our planet. We empower, support and inspire people over three decades of their journey in becoming world leading Deep Tech founders. Since 2015, we have supported over 150 startups solving global problems with groundbreaking advancements in healthcare, the environment and quality of life. We have two research facilities in Bristol, an award-winning venture capital arm (SCVC) …

67 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

Making the hope of early detection, a reality. Meet the team behind iBreastExam and cervAIcal! UE LifeSciences is a fast-growing, multi-national med-tech company bringing the promise of early detection of cancer to women globally. Our innovations have reached more than 250,000 women in 12 countries. We've grown revenue five-fold in the past three years with distribution in 10 countries and counting. And we've raised over $6 million in grants, international awards and equity capital! Our work is featured on platforms such as TED Talks and notable publications such as The New York Times, BBC World News, Forbes and others. Medical …

132 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical …

66 similar entities Type: Startup Activities: biotech deeptech

Accelerate drug time to market through real study traceability and unparalleled trial integrity At Verisian, we envision a world where groundbreaking treatments are judged using all available evidence and the best tools, where the science is transparent to companies, regulators, and patients alike, and where patients have access to the latest cutting-edge treatments as soon as possible. We’re building innovation for clinical research and public health authorities. While CDISC standards like SDTM and ADaM have brought standardization for clinical trial data, lengthy analysis and submission cycles remain just as increasing trial complexity presents substantial challenges in decision-making and the potential …

259 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics

Fujifilm has been evolving and transforming for more than 90 years. Building from our legacy of innovation in photographic film, today's Fujifilm is a technology company impacting the fields of healthcare, materials, business innovation and imaging. We will continue creating value from innovation, leveraging our advanced and unique technologies to solve social changes. We will never stop building our experience and expertise to transform ourselves and the world. To ensure a positive and respectful environment for all, we have established the community guidelines for participation: https://www.fujifilm.com/de/en/socialmedia/policy Medical Systems, Graphic Systems, Electronic Imaging, Photo Imaging, Optical Devices, Recording Media, and Industrial …

64 similar entities Type: SMB Activities: deeptech healthtech Technologies: New Materials

Science of certainty Gubra is a biotech company built on three synergistic business units, Biotech, CRO Services, and Ventures, united by a commitment to scientific excellence, strong partnerships, and responsible impact. ESG principles are embedded in our business model, including Gubra Green, our subsidiary that allocates 10% of pre-tax profits to support a net-zero, nature-positive future. Founded in 2008, Gubra has grown from a metabolic research specialist into a diversified organization of more than 300 scientists and experts. Today, we advance proprietary therapeutic programs, deliver high-end preclinical research services to global partners, and create new drug discovery opportunities through agile …

118 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Translating Complex Biology into Breakthrough Medicines InterAx is redefining drug discovery by understanding treatment impact on diseases before pre-clinical trials begin, an analysis traditionally inaccessible to very early programs. Focusing on GPCR small molecules, the Deep SignalTM platform enables superior optimization of drug candidates, leading to differentiated drugs with higher efficacy and safety and lower clinical failure rates. InterAx’s three-asset portfolio demonstrates this impact, including a biologically differentiated GLP-1 asset that addresses the challenges seen with small-molecule competitors, a partnered GIP program, as well as an innovative ACKR3 program driven by unique target understanding. With four additional targets identified, the …

131 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Panacea is a coordinated force for healthcare transformation. Panacea is a coordinated force for healthcare transformation. We are a system of convergence, purpose-built to redesign how breakthrough science becomes real-world impact. We operate across venture building, capital deployment, and ecosystem design to engineer a healthier, fairer, and faster future. AI, Venture Capital, Advanced Pharmaceuticals, Biotech, Medical Technology, Healthtech, Investment, Innovation, Digital Health, and Sustainability

67 similar entities Type: Startup Activities: deeptech Technologies: A.I.

We invent for life! At MSD - known as Merck & Co., Inc. in the United States and Canada, headquartered in Rahway, New Jersey - we are united by our purpose of harnessing the potential of science to save and improve lives around the world. For more than 130 years, we have provided hope through the development of important medicines and vaccines. We aspire to be the world's leading biopharmaceutical research company and are currently at the forefront of research into innovative health solutions to advance the prevention and treatment of human and animal diseases. We foster a diverse and …

237 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Legal + strategy consultancy for healthcare and life sciences Dierks+Company is a legal + strategy consultancy for healthcare and life sciences. D+C advises clients at the intersection of pharmaceuticals, medical devices, data and diagnostics. D+C provides comprehensive, long-term support for projects, combining legal, medical, strategic, economic, political and operational expertise within our team. We advise organizations that contribute to medical progress and improve people's lives. We do this by: 1. Navigate innovative products and services into the European market 2. Accelerate the transformation of the healthcare system 3. Shape Germany as an outstanding place for research Imprint: https://www.dierks.company/imprint/ Innovation, Healthcare …

246 similar entities Type: SMB Activities: biotech deeptech healthtech legaltech Technologies: Data Analytics

Integrated CDMO & Consultancy | Cell & Gene Therapy Experts | From CMC Strategy to GMP Manufacturing & Facility Design eXmoor Pharma is the only integrated UK cell and gene therapy CDMO with consultancy expertise embedded at every stage of your journey, from early-phase strategy through GMP manufacturing to commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and costs. Our purpose-built process development and GMP manufacturing facility offers end-to-end solutions across …

168 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees …

258 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Shaping the future of Life Sciences EXECUTIVE SEARCH LEADERSHIP ADVISORY SPECIALIZED IN LIFE SCIENCES At Hahn Zekker, we support Life Sciences companies (MedTech, Pharma, Biotech) to attract, assess, and develop transformational leaders globally. With 20+ years’ international experience, we partner with ambitious organizations to drive growth, innovation, and impact through people. Let’s shape the future of Life Sciences, together. Life Sciences, Pharma, Medtech, Biotech, Medical Devices, Start-Up, Executive Search, Coaching, Mentoring, Training, Assessment, HR, Consultancy, and Advise

Type: Startup Activities: deeptech biotech

Supporting health technologies throughout their maturation cycle. A network of expertise composed of reactive platforms, which answer the “Why, When and How to carry out preclinical and clinical studies”. The network aims to encourage initiatives and facilitate the realization of multidisciplinary and collaborative translational research projects in the field of evaluation of medical devices, e-Health and biomaterials. It is a national network bringing together academic expertise in regulation and evaluation serving the development of medical devices, e-Health and biomaterials throughout their life cycle. These axes may expand according to needs, strategic issues and network resources. Tech4Health positions itself as a …

165 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

The Future of Cancer Therapy The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium. For further information, please visit the EORTC website: www.eortc.org

54 similar entities Type: SMB Activities: biotech deeptech

Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other …

141 similar entities Type: SMB Startup Activities: biotech deeptech Technologies: Synthetic Biology

The #1 destination for daily news and insights on the fast-growth longevity market. LCW:the gateway to longevity clinics Just how close is technology that will enable humans to have hyper-extended lifespans? Closer than you think. Our mission is to bring together innovators, researchers, insurers, policy-makers, practitioners and commentators to address the new and fast-growing science and investment category that will shape the future of both the world’s population and the global economy: LONGEVITY Organ replacement, Nanotechnology, Senescence, Genetic engineering, Drug development, Artificial intelligence, Digital health, Man machine integration, and Eldercare

63 similar entities Type: SMB Activities: biotech deeptech Technologies: A.I.

Redefining Nutritional Health. Advancing the industry through precision, data, and global innovation. REVIV has been redefining nutritional health for over 14 years, advancing the industry through precision, data, and innovation. As the global leader in IV therapy and precision nutrition, we have built the infrastructure for the future of personalized health — transforming how the world experiences precision healthcare. Backed by a dedicated Life Sciences team and clinical expertise spanning more than a decade, REVIV integrates science, technology, and clinical intelligence to pioneer a new era of intelligent health. Our multidisciplinary team of doctors, pharmacists, and scientists work across clinical …

48 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, …

99 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology

AI-native pharmaceutical company We are an AI-native pharmaceutical company transforming scientific innovation from Africa and the UK into high-impact global health solutions. By combining cutting-edge artificial intelligence with regional biomedical expertise, we accelerate drug discovery and development—turning underutilized insights into scalable therapeutic assets. Our mission is to close the innovation gap, reduce R&D timelines, and deliver next-generation treatments to patients worldwide.

184 similar entities Type: Startup Activities: biotech healthtech Technologies: A.I.

Nasdaq: PAVM PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. cardiology, orthopedics, gastroenterology, and healthcare economics

256 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Turning clinical endpoints into value-driven milestones. Your trusted development partner. Part of Comac Medical Group. 🤝With over 25 years of experience and more than 30 supervised clinical trials, our team is specialised in early clinical development, transforming clinical data into value-creating assets for your company. We support leading biotechs such as ImCheck Therapeutics, Hephaistos Pharma, and Brenus Pharma, as well as prestigious clinical sites, like Gustave Roussy. Our expertise in FIH and PoC studies enables us to generate critical data that enhance your assets’ value and support your fundraising efforts. ILife is now part of Comac Medical Group, bringing clients …

288 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​ Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​ We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, …

225 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We Embrace the Challenge in Science Dompé is a private, family-owned biopharmaceutical company with more than 130 years of independent history, focused on redefining treatments for ophthalmic, neurological, and pain-related conditions through breakthrough science. As the first company to unlock the therapeutic potential of nerve growth factor (NGF), Dompé is advancing first-in-class, disease-modifying therapies that target the underlying causes of nerve damage rather than symptoms alone. Building on Nobel Prize-winning science, our work has already led to the approval of the first topical biologic in ophthalmology for a rare neurotrophic eye disease, and continues to expand into high-unmet-need areas across …

188 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Through its subsidiaries, Mayoly is a family-owned, independent, French pharmaceutical and dermatological laboratory with an international footprint. For more than a century, it has successfully been growing its business with a focus on Gastroenterology and Dermocosmetics. Our French industrial heritage relates to our values ​​of Responsibility, Pragmatism and Caring. We strive passionately and tirelessly to provide patients and people with the best possible healthcare daily, and aim to establish ourselves as a leader in Consumer Healthcare over the coming decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general medicine and general public health. We are …

288 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Pyramid studio embodies an unique way of leading therapeutic innovation to fuel the pipeline of pharmaceutical companies Pyramid Studio is a First-of-its-Kind venture builder dedicated to fuel the pipeline of pharmaceutical companies Pyramid Studio embodies a new way of leading therapeutic innovation through a unique build-to-buy model. Our mission is to bridge the gap for pharmaceutical companies seeking access to breakthrough innovations and delivering new therapies to patients. In practice, our team identifies and rigorously selects groundbreaking innovations from top academic teams across Europe. We collaborate closely with our Pharma partners to co-develop and co-finance these programs, ultimately delivering IND-ready …

293 similar entities Type: Incubators & VCs Startup Activities: deeptech biotech Technologies: Synthetic Biology

Medincell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition …

577 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Translating genetic discoveries into safe and effective treatments. Arctic Therapeutics is a clinical-stage biopharmaceutical company on a mission to treat and even prevent some of the world’s most pressing diseases by utilizing genetic sequencing to analyze and map the genetic causes of diseases at a granular level, applying our findings to develop effective treatments. Our company was founded by Dr. Hakon Hakonarson in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG), which he launched in 2006 and established it as the largest pediatric biobank and genomic database in the world. We maintain close research relationships with …

368 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Advice for Health industries - Partner of Lifesciences Industries. #Pharmaceutical #MedTech #Veterinary Caduceum: The 100% health expert to accelerate your industrial projects Since 2013, Caduceum has established itself as THE partner of choice for players in the health industries. A specialized Life Sciences subsidiary of the ALTEN group, we support pharmaceutical, biotechnology, MedTech, veterinary, cosmetics and nutritional health manufacturers. Our mission? Design, industrialize and optimize your products, from idea to marketing. Our strength? Cutting-edge expertise and a tailor-made approach, supported by more than 400 passionate employees who work across the entire value chain: ✔ Compliance & Quality: Compliance and operational …

286 similar entities Type: SMB Activities: healthtech transporttech biotech deeptech Technologies: SaaS

Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology

337 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We were made for this 53Biologics is a end-to-end biologics CDMO built to keep progress moving. By combining scientific expertise, integrated in-house capabilities and a collaborative way of working, we enable confident decision-making as biologics programs evolve. We support your biologic from early development to commercialization. With USP and DSP development, GMP manufacturing, quality control and fill-finish connected under one roof, we reduce handoffs, protect continuity and help clients grow without disruption. We were made for this. Biopharmaceuticals , CDMO, pDNA, Recombinant Protein, GMP, Drug Development, Microbial Manufacturing, Cell Banking, and GMP Manufacturing

353 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Excellis Health Solutions is an NNIT Group Company. Life sciences and public sector professionals can make a direct difference in the lives of the many – and with the digital revolution, the opportunities to make a mark are greater than ever. At NNIT, we bring digital transformation to life. You get a team of leading industry subject-matter experts and technology consultants. We develop, implement, and continuously improve sustainable solutions that help to enhance the quality of life around the globe. We overcome complexities through determined customer centricity and proximity. Our team is built around a pioneering spirit, conscience-driven approach, and …

104 similar entities Type: SMB Activities: deeptech biotech Technologies: Decarbonization

The Mechanisms-Based Medicine Company Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADITM Discovery models. We propose to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses. Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed with our partners CADITM Discovery capability to generate outstanding value through: • Strong & long term strategic R&D collaborations (>100 …

135 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: A.I.

AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10TM, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and …

225 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking. We are committed to seeking better outcomes which compels us to ask questions that have not been asked before or remain unresolved. We are driven by a desire to create meaningful impact across business, health and society to ease the burden on people living with chronic diseases. Intarcia is a rapidly emerging biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease. Our cross-disciplinary teams include forward-thinking scientists and entrepreneurs collaborating in a fast-paced environment redefining the future of medicine.

81 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Transforming Labs with AI and Automation Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on …

135 similar entities Type: Startup Activities: deeptech biotech Technologies: Robotics

Transforming lives with groundbreaking treatments Coultreon Biopharma's mission (formerly Onco3R Therapeutics) is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs. The team is leveraging their knowledge and expertise to bring transformative innovations to patients suffering from auto-immune diseases. In this field, there is an urgent need for more convenient oral drugs that can offer greater efficacy with a better safety profile. Drug Discovery, Drug Development, Immunology, Biotech, and R&D

826 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Helping health & biotech companies, researchers and entrepreneurs making their projects and dreams come true. GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers. Based in our expertise we help entrepreneurs and researchers to shape their business plan and we support them in the private fundraising process. We have raised 68,5 M€ in the last years in 20 rounds. We are Associate Partner at EIT Health and we are engaged to 23 EU projects with …

254 similar entities Type: SMB Activities: deeptech healthtech consulting entrepreneurship fintech biotech Technologies: A.I.

Moving pharmaceutical companies to expand access to their products in low- & middle-income countries The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and …

117 similar entities Type: SMB Activities: healthtech civictech deeptech biotech Technologies: Synthetic Biology

We are a biopharmaceutical company dedicated to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

284 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

BioCryst Pharmaceuticals is a commercial-stage biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, led by the efforts of our team of expert scientists in our Discovery Center of Excellence in Birmingham, Alabama. Our global headquarters is in Durham, North Carolina, we have a regional office in Boston, Massachusetts, and our employees span the globe across sites in multiple countries. We are proud of our culture of engagement and …

409 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Building the next generation of healthcare companies Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 20- 25 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders. We take a long-term view, underpinned by a strategic capital base which enables us to maintain significant ownership positions in our companies and provides us with control and flexibility over the management of …

50 similar entities Type: SMB Activities: biotech Technologies: Decarbonization

Providing innovative services to the healthcare industry, professional societies and patient groups. Today's most complex therapies in oncology, rare disease and specialty biologics have evidence journeys that are long and stakeholders that are sophisticated. But the industry meant to move them forward still operates in two halves: science on one side, commercialization on the other. Somewhere in the handoff, context gets lost. This is the gap Oxford PharmaGenesis and Klick Health are joining forces to close. Oxford PharmaGenesis is the leading HealthScience communications consultancy, renowned for scientific communications, medical affairs, publications strategy and market access consulting. Klick Health is the …

259 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics

Fueled by Connections to Transform Rare DiseasesTM Agios is a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment. Fueled by connections, we build trusted partnerships with rare disease communities, collaborating to develop and deliver innovative medicines with the potential to transform lives. Rooted in hematology, we combine deep biological expertise with real-world insights to advance a growing pipeline of medicines that reflect patients’ priorities. Our inclusive, collaborative culture sparks bold thinking and strengthens our connections – with each other and with the people we serve. Review our social media guidelines: https://www.agios.com/community-guidelines/ Biopharmaceuticals, Cellular Metabolism, and Rare …

312 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Unlocking the full potential of genetic medicines. At Nvelop, we are working to address the complex challenge of effectively delivering genetic medicines to target cells within the body (in vivo) in order to help treat patients with previously undruggable diseases. Our team is advancing two next-generation delivery platforms, started in the labs of our scientific co-founders Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung formerly of Mass General Hospital. We will use these platforms to build a pipeline of therapeutics internally and to enable strategic partners. We are building a culture and organization …

126 similar entities Type: Incubators & VCs Startup Activities: biotech deeptech Technologies: Synthetic Biology

MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding. Our team operates the projects and new companies to bridge the gap between science and clinical experience. We source innovations that are too early for large corporate or venture investors. These inventions arise from clinicians all over the world who do not wish to become entrepreneurs Our ambition is to turn these …

95 similar entities Type: Incubators & VCs SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as …

260 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Limitless solutions for people's health BIOCORP is a French company specializing in connected devices. Since October 2023, BIOCORP is a 100% Novo Nordisk company. The production plant is located in Issoire and the R&D and operational support teams in Clermont-Ferrand. Every day, our 100 employees are mobilised around a single objective: to offer professional innovative solutions improving the daily life for patients. We develop innovative connected devices helping in the management of various diseases. As an example, we are offering Mallya, a medical device dedicated to patients living with diabetes, turning any insulin pen into a smart device. Our company …

321 similar entities Type: SMB Activities: healthtech deeptech Technologies: Sensors

For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit. Biotechnology, mRNA, CDMO, and Services

127 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth …

179 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

582 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

A global leader in life sciences. Advancing quality, innovation, and confidence in results. Nova Biomedical is entering a new chapter. Advanced Instruments and Nova Biomedical have united to form a larger, more focused global life science tools company operating under the Nova Biomedical name. By bringing together two innovation‐driven organizations, we have expanded our capabilities across bioprocessing and clinical diagnostics, strengthening how we serve customers and accelerating our impact across life sciences. Today’s Nova Biomedical is a global leader in supporting bioprocessing workflows and in vitro diagnostics (IVD), guided by a renewed leadership team, sharper priorities, and a clear focus …

247 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

CRO with extensive expertise in small molecule chromatography and purification We are Neopharm Boston Inc., formerly Averica Discovery Services, a Contract Research Organization (CRO) recognized by our proficiency in small molecule analysis and purification. Our enduring legacy of excellence positions us as a strategic partner within the pharmaceutical industry. Our recent expansion has equipped us to deliver a comprehensive, fully integrated array of services, facilitating a seamless journey from development and preclinical stage to commercial launch. At Neopharm Boston, our remarkable high throughput capabilities extend beyond advanced instrumentation to encompass a highly skilled and capable team. This synergy enables us …

139 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Striving to improve and extend patients' lives Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to …

174 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

In-silico drug development for API small molecules ⚛️ Our AI-driven platform fuses quantum physics, machine learning, and high-performance cloud computing to simulate crystal formation and address one of pharma’s most critical challenges: polymorphism. The impact? Weeks instead of months. Certainty over guesswork. Global Pharmaceutical leaders trust us to reduce risk, accelerate timelines, and boost the success rate of new drugs. Backed by Enterprise Ireland, the EIC Accelerator, and strategic partners like Viridien (formerly CGG), we’re scaling fast. Follow along as we change how the world brings medicines to life. Computational Chemistry, Molecular Modeling, and AI Drug Development

149 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning

Engineering Stroke Solutions ENGINEERING Stroke Solutions Acandis, founded in 2006, is a privately held German medical device company focused on the prevention and treatment of stroke. We have a passion for technology and our engineers are enthusiastic about creating solutions for unmet clinical needs to improve patient’s lives. We strive towards a comprehensive device portfolio and continuous development of products and services to improve stroke care for neurointerventionalists around the globe. The safety of our products has been demonstrated on the bench top and now the efficacy of those products is being proven in clinical trials. As a company we …

296 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Driving innovation beyond convention We believe that science-powered innovation creates possibilities. As a privately held, fully-integrated global company, Revance is passionately driven by that philosophy in everything we do. Dedicated to offering a diverse portfolio in aesthetics, skincare, and therapeutics, our science-backed products care for individuals across the generations. By driving innovation beyond convention, we continue to research and develop differentiated products for health, beauty, and wellness. Botulinum Toxin, biotechnology, biotech, healthcare, science, and research

72 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Accelerating Medical Innovation PBC Biomed partners with medical device, biologic and pharmaceutical companies to support their innovation projects from design & development, through to commercialisation. We have developed a deep knowledge of the R&D, Regulatory, Quality Assurance, Clinical, Commercialisation and Vigilance requirements facing innovators based in Europe and those wishing to enter the European marketplace. We can now offer a CMO capability. Based in Ireland we partner with clients from start-ups to multinationals and use our knowledge, capabilities and global surgeon and commercial networks to 'Accelerate Medical Innovation'​. R&D - Medical Devices & Biologics, RA/QA - Medical Devices & Biologics, …

257 similar entities Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

Driving Innovation in Health At Farmalider, we believe in ideas as a driving force for progress. We know that true innovation comes from merging a brilliant idea with the ability to transform it into real improvements in people's health. With over 39 years of experience as a pioneering strategic partner in pharmaceutical innovation, we offer a comprehensive service that spans from ideation and development to intellectual property, licensing, manufacturing, and supply. Our commitment to continuous improvement, solid knowledge, and adaptability allows us to make a difference every day, building sustainable relationships with our clients. For this reason, we offer both …

133 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

#BeyondBoundaries At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment. Over the past 20 years, we’ve earned a track record of real impact: 60+ advanced candidates, 200+ patents filed, 200+ active projects. Over 90% of our customers choose to stay with us – from biotechs racing to clinic to pharma companies that …

279 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology